Bioaster Fondation de Cooperation Scientifique

Bioaster Fondation de Cooperation Scientifique is a research organisation in Lyon, France that has taken part in 11 EU-funded projects since 2014, receiving €5.5M in EU funding.

EU funding received€5.5M
EU projects11
As coordinator0
Running now3
First EU project2014
Latest project2024
CountryFrance
EU registration (PIC)952786381
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bioaster Fondation de Cooperation Scientifique's own share of each project, not the project's full budget.

  • Horizon 2020€3.9M · 8 projects
  • FP7 (2007 to 2013)€859k · 1 project
  • Horizon Europe€724k · 1 project
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

11 EU-funded projects, newest first. Each links to the official record.

  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • Homi-lungPartner

    Long-term alterations of host-microbiome interactions and cardiovascular and respiratory diseases progression after pneumonia

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €724ktheir share
  • INCENTIVEPartner

    Indo-European Consortium for Next Generation Influenza Vaccine Innovation

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €643ktheir share
  • TRANSVAC-DSPartner

    DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €75ktheir share
  • ImmunoSepPartner

    Personalized immunotherapy in sepsis: a precision medicine based approach

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €457ktheir share
  • ERA4TBPartner

    EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €1.8Mtheir share
  • GNA NOWPartner

    NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €346ktheir share
  • VALUE-DxPartner

    The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €64ktheir share
  • FunHoMicPartner

    Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €275ktheir share
  • TRANSVAC2Partner

    European Vaccine Research and Development Infrastructure

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €192ktheir share
  • NAREBPartner

    Nanotherapeutics for antibiotic resistant emerging bacterial pathogens

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

    €859ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • artificial intelligence
  • bacteriology
  • catalysis
  • diabetes
  • drug discovery
  • governance
  • immunology
  • immunotherapy
  • infectious diseases
  • influenza
  • metabolomes
  • microbiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime